Apollo Healthtech targets listing by Jan-Mar 2027
Apollo Healthtech
, the demerged
omni-channel pharmacy
and
digital health
business of
Apollo Hospitals
, is likely to be listed by January-March 2027, a top company official said Tuesday.
Asked if there are plans of a family reorganisation, Apollo Hospitals group chief financial officer Krishnan Akhileswaran told ET, "No, there isn't. It's just a value unlock for shareholders. The promoters of Apollo will also be the promoters of the new company, and they will also be directors in the new company. So, there is no change from that standpoint."
Finance
Value and Valuation Masterclass - Batch 4
By CA Himanshu Jain
View Program
Artificial Intelligence
AI For Business Professionals Batch 2
By Ansh Mehra
View Program
Finance
Value and Valuation Masterclass - Batch 3
By CA Himanshu Jain
View Program
Artificial Intelligence
AI For Business Professionals
By Vaibhav Sisinity
View Program
Finance
Value and Valuation Masterclass - Batch 2
By CA Himanshu Jain
View Program
Finance
Value and Valuation Masterclass Batch-1
By CA Himanshu Jain
View Program
Double-digit growth
Apollo Hospitals, India's largest pan-India hospital chain by revenue, announced its first quarter results post market hours on Tuesday. It posted a 42% on-year rise in first quarter consolidated net profit to ₹433 crore, driven by double-digit growth in all business segments.
Revenues for the quarter grew 15% on-year to ₹5,842 crore, driven by higher patient volumes and growth in diagnostic footprint. The company saw 26% rise in earnings before interest, taxes, depreciation, and amortisation to ₹852 crore. It had earlier in the quarter announced spinning off its omni-channel pharmacy and digital health business into a new entity Apollo Healthtech.
CCI, NCLT nods
"The application to the stock exchanges have been already made and once their approval is received, we can file to the CCI (Competition Commission of India) and NCLT (National Company Law Tribunal) simultaneously. We expect the listing to happen around January-March of 2027. Some of the NCLT-related approval should come much before that," Akhileswaran elaborated.
Apollo Hospitals Enterprise chairman Prathap C Reddy said, "The demerger of our digital health and pharmacy business, approved in the last quarter, is now in the implementation phase. This strategic move will enable focused capital allocation and sharper growth plans with dedicated management teams for both hospital operations and omnichannel healthcare ecosystem."
The hospital chain aims to add 4,370 beds through acquisition, brownfield and greenfield expansion over the next 3-4 years, with the first phase of 2,000 beds is already in progress. "Patient numbers across our network increased year-on-year. The quarter saw us announce our ambitious growth strategy to add over 4,300 beds in the next five years with an investment of over ₹7,600 crore," said Dr Reddy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
9 minutes ago
- News18
In Tit-For-Tat Move, China Sanctions Two European Union Banks
The move came as a direct response to the EU's earlier decision to sanction two Chinese regional banks — Heihe Rural Commercial Bank and Suifenhe Rural Commercial Bank. In a sharp counter to European financial pressure, Beijing has imposed sanctions on two small Lithuanian lenders — UAB Urbo Bankas and AB Mano Bankas — barring them from conducting any transactions or cooperating with individuals and organisations in China. The measures, announced on August 13, 2025, were declared effective immediately by China's Ministry of Commerce. The move came as a direct response to the EU's earlier decision, effective August 9, to sanction two Chinese regional banks — Heihe Rural Commercial Bank and Suifenhe Rural Commercial Bank — under its July sanctions package over concerns that these institutions facilitated Russia-related financial activity. China, vehemently rejecting the EU's allegations as 'groundless," criticised the sanctions for undermining longstanding economic and trade cooperation with Europe. Beijing urged the European Union to reconsider its actions to protect bilateral ties in trade, economy, and finance. As diplomatic tensions simmer, EU officials indicated they are reviewing China's reaction and remain open to negotiations that might lead to reversing the sanctions, if a mutually acceptable solution is reached. At the heart of this standoff lies a tit-for-tat escalation in the realm of financial sanctions. The EU, aiming to tighten its grip on Russia by targeting enablers of its war efforts, included two Chinese banks in its sanctions list on August 9. Viewing this move as a direct affront, China promptly retaliated by hitting two Lithuanian institutions — symbolic actors but strategically relevant — as a signal that retaliatory measures would follow any aggression. This move reflects broader strains in EU-China relations, stoked by disagreements over trade imbalances, alleged Chinese support for Russia, and competing economic interests. With high-level meetings such as recent summits having failed to clarify common ground, the tit-for-tat banking sanctions underscore a deeper erosion of trust and growing readiness on both sides to leverage financial tools for geopolitical signaling. view comments Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
12 minutes ago
- Time of India
The new distribution math: UFC's shift from PPV culture to Paramount+ bundling
Since its first ESPN deal in 2018, a five-year contract valued at $1.5 billion, the UFC grew familiar with PPV economics under the cable-and-satellite model. The UFC's major events generated revenue by selling individual shows at premium prices, often $60 to $80 per event, on top of existing distribution fees paid by networks. ESPN amplified UFC's visibility via integrated studio segments, weigh-in coverage, and highlights across SportsCenter and other properties, solidifying the UFC's place in mainstream sports media. This era helped elevate both brand awareness and PPV volumes. Now, with ESPN's contract expiring at the end of 2025, the UFC has secured a new seven-year, $7.7 billion US rights deal with Paramount Global . Under this framework, all events, including numbered cards and Fight Nights, will be available on Paramount+, while select marquee cards will simulcast live on CBS. The deal's headline figure dwarfs the previous agreement; however, the shift in delivery models critically transforms how revenue is structured and how audiences engage. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Also read: Dana White gives major update on proposed UFC fight at the White House by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Subscription bundling vs. event-by-event PPV In the traditional PPV world, consumers pay per event, often motivated by star power and marquee matchups. That model creates spikes in revenue tied to each big card but places purchasing decisions squarely in viewers' hands every time, a dynamic that can hurt overall event uptake, especially for casual fans. Under ESPN, the UFC's PPV model relied on both the promotion's marketing muscle and ESPN's promotional ecosystem to drive sales. The Paramount+ model moves to subscription-based bundling: UFC events become part of a broader content package. Consumers with subscriptions pay a flat monthly or annual fee, removing per-event friction but also potentially dampening per-card revenue excitement. The success now depends on subscriber growth and retention, whether enough viewers subscribe to Paramount+ primarily for UFC content, or maintain subscriptions long-term. Viewers get more inclusive access, potentially increasing casual viewership, but the promotional juggernaut that ESPN offered, a constant highlight of UFC content in daily programming, is diminishing. Bundling benefits, and risks for viewers and fighters For fans, the all-access model may appear advantageous. Paying for a single service that delivers multiple UFC events removes the pinch of paying $60–$80 per card. It supports binge consumption and discovery, a casual viewer might sample a fight night without extra cost, encouraging engagement. Meanwhile, broadcaster bundling aligns with evolving consumer behavior, favoring flat-rate, multi-content experiences. Live Events But for fighters and promoters, this shift may reduce per-event revenue spikes that PPV models deliver. Under PPV, UFC created direct event revenue and often shared PPV points with high-profile fighters, meaning big-name cards could yield substantial payouts. In the new structure, those spikes may flatten into distributed revenue across subscription tiers. Unless UFC negotiates more favorable revenue-sharing structures or views Paramount+ subscriptions as functionally equivalent to PPV volume on aggregate, fighter compensation dynamics could change. Whether Paramount+ pricing and subscriber growth can replicate, or exceed, total PPV revenue is uncertain, although the $7.7B rights deal provides a baseline. Also read: Paramount acquires UFC rights for $7.7 billion to boost streaming Distribution reach and exposure Paramount+ currently has approximately 77–78 million global subscribers. CBS remains the most-watched broadcast network in the US, dominating primetime ratings. This offers UFC both streaming reach and network visibility for select events. In contrast, ESPN's daily cable viewership and social-media promotions created constant exposure for the UFC. The shift may trade high-volume, event-by-event marketing for concentrated promotions around major cards on CBS. Although UFC may no longer receive heavy exposure as a daily feature across ESPN platforms, it gains access to Paramount+ subscribers and broadcast reach for marquee cards through CBS. Audience habits are rapidly shifting toward streaming: Nielsen reports that streaming has, for the first time, eclipsed combined broadcast and cable viewing in viewership. The model aligns with broader industry movement toward direct-to-consumer (DTC) distribution. The broader industry context The UFC's new arrangement mirrors a broader sports-media trend: marquee content migrating from PPV or cable-based packages to streaming-first distribution. This migration reflects shifting economics in content consumption, where maximal reach is nested in bundled offerings rather than per-item price spikes. The NFL , NBA, and other leagues are exploring or embracing similar models, often through exclusive streaming rights deals or app-based packages. For fans accustomed to choosing individual fight nights, this new paradigm emphasizes subscription maintenance over per-event purchase. Conversely, fans who paid only for select PPV events might now consider shelling out monthly for bundled access. Whether the shift encourages more consistent viewership or loses engagement due to 'subscription fatigue' will be closely watched. Implications for UFC's financial model The new deal represents a marquee annual figure, over $1 billion per year, solidifying the UFC's valuation as a global sports brand. It secures multi-year revenue certainty and aggregates the rights fees into one major partnership. For corporate leadership and fighters, that predictability offers benefits, but may require new compensation formulas. If previously lucrative PPV points disappear, blockbuster paydays may shift to salaries, bonuses, or share of subscription jump spikes tied to all-content releases. Crucially, UFC's leadership, led by Dana White, had sufficient leverage to command premium pricing even as they migrated platforms. But this transition tests a fundamental understanding: are consumers willing to adopt subscriptions rather than pay per fight, and will the model be more profitable in aggregate? Also read: UFC -Paramount+ $7.7 Billion Deal in U.S.: What's included and will fans face higher costs for live sports Long story short The UFC's move from ESPN to Paramount Global marks more than a rights transfer, it signifies a tectonic shift in how live combat sports are packaged and delivered. UFC is trading the PPV model, with its episodic revenue bursts, for a bundling model that favors subscriber scale and platform integration. Viewers may benefit from reduced per-event friction and increased accessibility. Fighters and promoters must recalibrate revenue expectations and value creation models. Meanwhile, UFC's success under Paramount+ will largely depend on its ability to drive subscriptions and maintain engagement without the constant promotional funnel ESPN provided. This new distribution math reflects the evolving media landscape: a world where continuous content access takes precedence over event-by-event spending, marking the UFC's latest chapter in adapting to streaming-era economics.
Time of India
15 minutes ago
- Time of India
Apollo Hospitals shares in focus as brokerages hike target prices post strong Q1FY26 results
Apollo Hospitals shares are likely to be in focus on Thursday, August 14, after the company posted a strong set of Q1FY26 results , prompting multiple brokerage firms to raise their target prices for the stock. The healthcare major reported a consolidated net profit of Rs 433 crore for the quarter ended June 30, 2025, marking a 42% year-on-year increase from Rs 305 crore in the same period last year. On a sequential basis, PAT was up 11% from Rs 390 crore in Q4FY25. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Revenue from operations in Q1FY26 rose 15% year-on-year to Rs 5,842 crore compared to Rs 5,086 crore in Q1FY25. Sequentially, revenue grew 4.5% from Rs 5,592 crore in the March quarter. The robust performance was supported by growth across segments, improved specialty mix, and operational efficiency gains. Nuvama: Buy| Target price: Rs 9,010 Nuvama has raised its target price for Apollo Hospitals to Rs 9,010 from Rs 8,635, maintaining a 'Buy' rating. Live Events The brokerage noted strong performance from HealthCo and said sustained execution remains key. It expects hospital growth from H2FY26 through phased bed expansion, higher international patient inflows, and an improved specialty mix. Nuvama also highlighted potential value unlocking from the Keimed merger, front-end restructuring, and a possible listing within 18 months. HealthCo's valuation multiple was raised to 26x from 22x, and FY26E/FY27E EBITDA estimates were increased by 2% and 4%, respectively. Motilal Oswal: Buy| Target price: Rs 9,010 Motilal Oswal also raised its target price to Rs 9,010 from Rs 8,720 while maintaining a 'Buy' rating. The firm cited broad-based growth with EBITDA and PAT beating estimates on cost optimisation and noted that profitability was boosted by lower operating expenses. It highlighted a 14% year-on-year rise in surgical revenues on the back of strong CONGO therapy momentum. HealthCo is on track for cash EBITDA breakeven (excluding ESOP) by Q2FY26/Q3FY26. The brokerage expects 15%, 21%, and 28% CAGR in revenue, EBITDA, and PAT, respectively, over FY25–FY27 and has raised its FY26/FY27 earnings estimates by 7%. Avendus: Buy| Target price: Rs 8,765 Avendus has increased its target price for Apollo Hospitals to Rs 8,765 from Rs 8,515, reiterating a 'Buy' call. The brokerage has advanced the breakeven timeline for the online business EBITDA to FY27 from FY28 earlier. It projects ex-Keimed revenue CAGR at 17% in FY25–FY27, with EBITDA expected at Rs 510 crore and Rs 770 crore for FY26 and FY27, respectively. Offline pharmacy revenue CAGR is also projected at 17%, while existing units' EBITDA CAGR is estimated at 16% in the same period. Avendus factors in the AHCo–Keimed merger in April 2026 and the APL front-end acquisition in April 2027. It expects healthcare services EBITDA CAGR of 14% and AHLL at 22% over FY25–FY27. FY26/FY27 EBITDA estimates have been raised by 4% each, driven by higher AHCo EBITDA, partly offset by new hospital losses. Also read: Zerodha's Nithin Kamath on how a boring, invisible Sebi step brought windfall gains for retail investors ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
